AU2001285489A1 - 5-ASA derivatives having anti-inflammatory and antibiotic activity and methods of treating diseases therewith - Google Patents

5-ASA derivatives having anti-inflammatory and antibiotic activity and methods of treating diseases therewith

Info

Publication number
AU2001285489A1
AU2001285489A1 AU2001285489A AU8548901A AU2001285489A1 AU 2001285489 A1 AU2001285489 A1 AU 2001285489A1 AU 2001285489 A AU2001285489 A AU 2001285489A AU 8548901 A AU8548901 A AU 8548901A AU 2001285489 A1 AU2001285489 A1 AU 2001285489A1
Authority
AU
Australia
Prior art keywords
compound
disease
hydroxy
pharmaceutical composition
carboxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001285489A
Other languages
English (en)
Inventor
Nnochiri N. Ekwuribe
Elizabeth Malson
Jennifer Riggs-Sauthier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nobex Corp
Original Assignee
Nobex Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nobex Corp filed Critical Nobex Corp
Publication of AU2001285489A1 publication Critical patent/AU2001285489A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/50—Compounds containing any of the groups, X being a hetero atom, Y being any atom
    • C07C311/51—Y being a hydrogen or a carbon atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AU2001285489A 2000-08-29 2001-08-28 5-ASA derivatives having anti-inflammatory and antibiotic activity and methods of treating diseases therewith Abandoned AU2001285489A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22868200P 2000-08-29 2000-08-29
US60228682 2000-08-29
PCT/US2001/041910 WO2002018330A1 (en) 2000-08-29 2001-08-28 5-asa derivatives having anti-inflammatory and antibiotic activity and methods of treating diseases therewith

Publications (1)

Publication Number Publication Date
AU2001285489A1 true AU2001285489A1 (en) 2002-03-13

Family

ID=22858177

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001285489A Abandoned AU2001285489A1 (en) 2000-08-29 2001-08-28 5-ASA derivatives having anti-inflammatory and antibiotic activity and methods of treating diseases therewith

Country Status (10)

Country Link
US (1) US6458776B1 (cg-RX-API-DMAC7.html)
EP (1) EP1313699B1 (cg-RX-API-DMAC7.html)
JP (1) JP5112595B2 (cg-RX-API-DMAC7.html)
AT (1) ATE460394T1 (cg-RX-API-DMAC7.html)
AU (1) AU2001285489A1 (cg-RX-API-DMAC7.html)
CA (1) CA2421114C (cg-RX-API-DMAC7.html)
DE (1) DE60141520D1 (cg-RX-API-DMAC7.html)
IL (2) IL154537A0 (cg-RX-API-DMAC7.html)
MX (1) MXPA03001786A (cg-RX-API-DMAC7.html)
WO (1) WO2002018330A1 (cg-RX-API-DMAC7.html)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2495537C (en) 2000-08-29 2010-03-30 Nobex Corporation Immunoregulatory compounds and derivatives and methods of treating diseases therewith
US8048924B2 (en) 2001-08-29 2011-11-01 Biocon Limited Methods and compositions employing 4-aminophenylacetic acid compounds
AU2003259381A1 (en) * 2002-08-29 2004-03-19 University Of Southampton Use of apoptosis inducing agents in the preparation of a medicament for the treatment of liver diseases
US20060264408A1 (en) * 2003-03-06 2006-11-23 Haj-Yehia Abdullah I Sod minic multifunctional compounds for treating inflammatory bowel disease
SE0300807L (sv) * 2003-03-25 2004-03-30 Sven Kindblom Stötdämpare för höjdreglering
PL1651249T3 (pl) 2003-07-23 2013-04-30 Novartis Ag Zastosowanie kalcytoniny w zapaleniu kości i stawów
NZ549661A (en) * 2004-02-06 2010-07-30 Pharmatel R & D Pty Ltd As Tru Use of aminosalicylates in diarrhoea-predominant irritable bowel syndrome
DE602005022175D1 (de) * 2004-05-28 2010-08-19 Salix Pharmaceuticals Inc Prävention, behandlung und linderung strahlungsinduzierter enteritis
EP1773767B1 (en) * 2004-07-07 2016-03-09 Biocon Limited Synthesis of azo bonded immunoregulatory compounds
US7498355B2 (en) * 2005-05-27 2009-03-03 Antibe Therapeutics Inc. Derivatives of 4- or 5-aminosalicylic acid
US7741359B2 (en) * 2005-05-27 2010-06-22 Antibe Therapeutics Inc. Hydrogen sulfide derivatives of non-steroidal anti-inflammatory drugs
WO2006125293A1 (en) * 2005-05-27 2006-11-30 Antibe Therapeutics Inc. Derivatives of 4- or 5-aminosalicylic acid
US20060270635A1 (en) * 2005-05-27 2006-11-30 Wallace John L Derivatives of 4- or 5-aminosalicylic acid
US8921344B2 (en) * 2006-11-03 2014-12-30 Salix Pharmaceuticals, Inc. Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives
NZ593132A (en) * 2005-08-24 2013-02-22 Salix Pharmaceuticals Ltd Balsalazide formulations and manufacture and use thereof
US7452872B2 (en) 2005-08-24 2008-11-18 Salix Pharmaceuticals, Inc. Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives
KR101432313B1 (ko) 2005-11-17 2014-08-20 노파르티스 아게 약제학적 조성물
EP1996710B1 (en) * 2006-03-09 2019-08-14 Salix Pharmaceuticals, Inc. Rifaximin anti-rectal dysfunction preparation
JP5421098B2 (ja) * 2006-06-06 2014-02-19 ジーアイケア ファーマ インク． トリメブチン及びｎ−脱メチル化トリメブチンの塩類
US7271253B1 (en) * 2006-08-10 2007-09-18 Apotex Pharmachem Inc. Safe process for the preparation of balsalazide
JPWO2008114831A1 (ja) * 2007-03-20 2010-07-08 国立大学法人 岡山大学 スルホンアミド基を有する抗菌剤
US20090098088A1 (en) * 2007-10-10 2009-04-16 The Procter & Gamble Company Methods And Kits For The Treatment Of Diverticular Conditions
CN102014926A (zh) * 2008-05-01 2011-04-13 宝洁公司 用于治疗炎性肠病的方法和试剂盒
CN105348184B (zh) * 2015-11-26 2020-12-29 苏州统华药品有限公司 一种柳氮磺吡啶的制备方法
IL271777B2 (en) 2017-07-07 2024-09-01 Epicentrx Inc Compositions for parenteral administration of therapeutic agents

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2270676A (en) * 1936-08-20 1942-01-20 Winthrop Chem Co Inc Sulphonic acid amide compound
US2396145A (en) * 1940-12-14 1946-03-05 Pharmscia Ab Heterocyclic sulphonamido azo compounds
BE791889A (fr) * 1971-11-26 1973-05-24 Pharmacia Ab Nouveaux derives de la pyridine
JPS5353449A (en) * 1976-10-22 1978-05-15 Sofuia Kk Picture type pachinko game machine
US4412992A (en) * 1980-07-21 1983-11-01 Biorex Laboratories Limited 2-Hydroxy-5-phenylazobenzoic acid derivatives and method of treating ulcerative colitis therewith
SU1011126A1 (ru) * 1981-07-14 1983-04-15 Всесоюзный научно-исследовательский и испытательный институт медицинской техники Средство дл лечени сахарного диабета
CS142691A3 (en) * 1991-05-15 1992-11-18 Vyzk Ustav Farm Biochem Sp Process for preparing 5-//4-/(4',6'-dimethyl-2-pyrimidinyl)sulfamoyl/phenyl/azo/-acetylsalicylic acid
SE9700934D0 (sv) * 1997-03-14 1997-03-14 Astra Ab New formulation

Also Published As

Publication number Publication date
IL154537A0 (en) 2003-09-17
JP5112595B2 (ja) 2013-01-09
MXPA03001786A (es) 2003-06-04
EP1313699B1 (en) 2010-03-10
EP1313699A1 (en) 2003-05-28
CA2421114C (en) 2010-12-07
WO2002018330A1 (en) 2002-03-07
US20020111334A1 (en) 2002-08-15
JP2004507521A (ja) 2004-03-11
DE60141520D1 (de) 2010-04-22
ATE460394T1 (de) 2010-03-15
IL154537A (en) 2013-07-31
US6458776B1 (en) 2002-10-01
CA2421114A1 (en) 2002-03-07

Similar Documents

Publication Publication Date Title
US6458776B1 (en) 5-ASA derivatives having anti-inflammatory and antibiotic activity and methods of treating diseases therewith
US6583128B2 (en) Immunoregulatory compounds and derivatives and methods of treating diseases therewith
AU2003284808B2 (en) The derivatives of pyridone and the use of them
AU2001285311A1 (en) Immunoregulatory compounds, derivatives thereof and their use
JP2008542291A (ja) 網膜疾患を処置するための組成物および方法
US10011614B2 (en) Bis-β-carboline compound and preparation method, pharmaceutical composition and use thereof
US11028111B2 (en) Compound for treating metabolic diseases and preparation method and use thereof
HRP20050517A2 (en) N-sulfonyl-4-methyleneamino-3-hydroxy-2-pyridones as antimicrobial agents
CN109996804A (zh) 用于治疗感染的角鲨胺酰胺衍生物
CN109640965A (zh) 用于治疗肠易激综合征的组合物和方法
CN118930507A (zh) 一种黄芩素衍生物及其制备方法和应用
HK1089749B (en) Use of a pharmaceutical composition containing a para-aminophenyl acetic acid derivative for treating inflammatory conditions of the gastrointestinal tract
US20210052537A1 (en) Colitis ameliorating agent
JP2023542455A (ja) ３－デオキシ－２－ケトアルドン酸窒素含有誘導体、その製造方法及びその使用
HK1054221B (en) Immunoregulatory compounds, derivatives thereof and their use
KR20190043013A (ko) 신규한 인다졸 유도체 및 이의 용도
CN102807514A (zh) 取代的苯二胺类衍生物及其制备方法和用途